Tradewinds Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $891 | Hold |
2
| – | – | ﹤0.01% | 528 |
|
2025
Q1 | $970 | Hold |
2
| – | – | ﹤0.01% | 541 |
|
2024
Q4 | $806 | Hold |
2
| – | – | ﹤0.01% | 563 |
|
2024
Q3 | $931 | Sell |
2
-2
| -50% | -$931 | ﹤0.01% | 520 |
|
2024
Q2 | $1.88K | Buy |
4
+2
| +100% | +$938 | ﹤0.01% | 448 |
|
2024
Q1 | $837 | Hold |
2
| – | – | ﹤0.01% | 472 |
|
2023
Q4 | $814 | Hold |
2
| – | – | ﹤0.01% | 396 |
|
2023
Q3 | $696 | Hold |
2
| – | – | ﹤0.01% | 411 |
|
2023
Q2 | $704 | Hold |
2
| – | – | ﹤0.01% | 399 |
|
2023
Q1 | $631 | Hold |
2
| – | – | ﹤0.01% | 407 |
|
2022
Q4 | $578 | Hold |
2
| – | – | ﹤0.01% | 440 |
|
2022
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 404 |
|
2022
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 420 |
|
2022
Q1 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 755 |
|
2017
Q4 | – | Sell |
-81
| Closed | -$12K | – | 751 |
|
2017
Q3 | $12K | Hold |
81
| – | – | 0.01% | 377 |
|
2017
Q2 | $10K | Hold |
81
| – | – | 0.01% | 397 |
|
2017
Q1 | $9K | Hold |
81
| – | – | 0.01% | 416 |
|
2016
Q4 | $6K | Hold |
81
| – | – | ﹤0.01% | 433 |
|
2016
Q3 | $7K | Hold |
81
| – | – | ﹤0.01% | 414 |
|
2016
Q2 | $7K | Hold |
81
| – | – | 0.01% | 411 |
|
2016
Q1 | $6K | Hold |
81
| – | – | ﹤0.01% | 456 |
|
2015
Q4 | $10K | Hold |
81
| – | – | 0.01% | 384 |
|
2015
Q3 | $8K | Hold |
81
| – | – | 0.01% | 394 |
|
2015
Q2 | $10K | Hold |
81
| – | – | 0.01% | 410 |
|
2015
Q1 | $10K | Hold |
81
| – | – | 0.01% | 377 |
|
2014
Q4 | $10K | Hold |
81
| – | – | 0.01% | 386 |
|
2014
Q3 | $9K | Hold |
81
| – | – | 0.01% | 388 |
|
2014
Q2 | $8K | Hold |
81
| – | – | 0.01% | 402 |
|
2014
Q1 | $6K | Hold |
81
| – | – | ﹤0.01% | 454 |
|
2013
Q4 | $6K | Buy |
+81
| New | +$6K | ﹤0.01% | 432 |
|